Global Peptide Synthesis Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Peptide Synthesis Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Peptide Synthesis market finds that the global Peptide Synthesis market reached a value of USD 670.16 million in 2022. It’s expected that the market will achieve USD 1023.81 million by 2028, exhibiting a CAGR of 7.32% during the forecast period.

Market Drivers
, Trends and Issues
The growing involvement of public and private institutions in synthetic biology research is contributing to the growth of the global market for peptide synthesis. The number of public and private entities engaged in the field of synthetic biology has increased dramatically in recent years. The growing involvement of research entities has led to an increase in overall research and development (R&D) investment in the development of innovative and advanced biology-based products to overcome global health challenges, including increased incidence of chronic diseases.
Major players in the peptide synthesis market are launching new products to gain a larger share of the market. In December 2018, for example, JPT peptide technology co., LTD., launched the 72 new antigen peptide and the peptide library PepMixes, used in T cell antigen specificity. Technological innovations have an important role in driving the growth of the market. To sustain in the competitive market, vendors should develop new ideas and technologies and stay up-to-date with the advanced technologies.

Region Overview:

From 2023-2028, China is estimated to witness robust growth prospects.

Company Overview:

The top three companies are GL Biochem, Hybio and Genscript with the revenue market share of 6.51%, 5.83% and 5.35% in 2018.

GL Biochem Shanghai Limited develops, manufactures, and distributes biological medicine products. The Company produces peptides, antibodies, amino acids, and related derivates. GL Biochem Shanghai sells its products domestic and international.

Hybio Pharmaceutical Co., Ltd. develops drug products. The Company manufactures and sells omeprazole sodium injection, somatostatin injection, desmopressin, antide, and other related products. Hybio Pharmaceutical also develops and sells medical testing products.

Segmentation Overview:

Among different product types, 75% to 85% segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Commercial segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Peptide Synthesis market covered in Chapter 3:

AnaSpec
PolyPeptide
New England Peptide
LifeTein
Biomatik
Genscript
JPT
Thermofischer
Bachem
Proimmune
GL Biochem
USVPeptides
ScinoPharm
Hybio
CPC Scientific

In Chapter 4 and Chapter 14.2, on the basis of types, the Peptide Synthesis market from 2018 to 2029 is primarily split into:

Under 75%
75% to 85%
Above 85%

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Peptide Synthesis market from 2018 to 2029 covers:

Commercial
Academic Research

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)